Insulin peglispro

Insulin peglispro, a cutting-edge and breakthrough long-acting insulin analogue, presents itself as a revolutionary therapeutic intervention against the formidable scourge of diabetes mellitus plaguing humanity. Its phenomenal attributes encompass remarkable extension of glycemic control, thereby effectively mitigating the pernicious adversity inflicted by hyperglycemia while staving off the grave complications accompanying elevated glucose concentrations.

Online Inquiry

Specification Technical Data Related Products Featured Products Customer reviews and Q&A Useful Tools Publications

CAT#	R2047
CAS	1200440-65-8
M.F/Formula	C370H566N104O110S4
M.W/Mr.	8359.32

CAT#	Product Name	Inquiry
R1824	Cyclo(RGDyK)	Inquiry
R1809	MTP-131; RX-31; SS-31 Elamipretide	Inquiry
R1127	[pThr3]-CDK5 Substrate	Inquiry
R1152	ACTH 11-24	Inquiry
R1483	LGnRH-III, lamprey	Inquiry

CAT#	Product Name	M.W	Molecular Formula	Inquiry
10-101-20	Goserelin Acetate	1269.43	C59H84N18O14	Inquiry
10-101-59	Liraglutide	3751.2	C172H265N43O51	Inquiry
R1574	Octreotide	1019.24	C₄₉H₆₆N₁₀O₁₀S₂	Inquiry
10-101-139	Myrcludex B			Inquiry
10-101-285	Teduglutide	3752.08	C164H252N44O55S	Inquiry
R1847	Sermaglutide	4114	C187H291N45O59	Inquiry
R1961	Carbetocin	988.2	C45H69N11O12S	Inquiry

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.